Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease. - Wikidata - awgldk - TriplyDB

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

http://www.wikidata.org/entity/Q37672615

about

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

http://www.wikidata.org/entity/Q37672615

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@en

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@nl

type

label

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@en

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@nl

prefLabel

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@en

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@nl

P1433

Q37672615-43970F1F-BB98-41E1-ABF6-02C9B4570775

P1476

Q37672615-0BFB1F96-6B1B-4369-A9D6-8D3B88E4AA12

P2093

Q37672615-1FB3ACE0-10FA-4D6E-9F8A-ACD3B5F15256

Q37672615-677B2493-D54A-4FF3-82E1-510F7AB01232

Q37672615-ACB5CB6F-BE61-45A5-9A5D-9FF444C14CCE

Q37672615-FAA20F2D-8A9C-43EF-833B-06135E36163E

P2860

Q37672615-1851EC6C-A5DC-49DF-9D39-E0726736C118

Q37672615-1AC9CBBA-C308-4698-B6DB-6C0FECCA9997

Q37672615-1D3E7D4D-B842-439B-B7C4-CAEE2A62A0D2

Q37672615-222A2C05-8BC9-4D43-B518-C26902A99A21

Q37672615-22972800-82A2-4279-828D-1B9F6520CCF8

Q37672615-2851AB09-F878-4EF7-AC75-1E93581BD5D9

Q37672615-289FF636-59BF-4E09-8A17-ED7B7EECFD0F

Q37672615-2D253A4A-5B72-483F-B345-96AC82FC5C7D

Q37672615-4A37D1CC-31C5-45C5-A8D7-DFFA9A42A78D

Q37672615-4DC419DF-8BA6-4936-99B3-A40BF04D103C

P304

Q37672615-D4EDA0AF-90AC-4C7D-BB35-50EB62389076

P31

Q37672615-75FF6F0F-0592-4713-872B-0E3F2B020DBF

P356

Q37672615-50D90FFC-9FDE-4ECB-8F04-FF4CCE07E648

P407

Q37672615-85421547-491F-49F7-A039-47E69AB9A639

P478

Q37672615-B70B4694-5ADE-42D2-8C1C-8F04BC7B62D8

P50

Q37672615-B310CAA5-E354-4B59-A430-366C56F9C79A

Q37672615-CE5896AE-E6F5-4A68-A49B-4DC2F6A00ACF

P577

Q37672615-D50CC415-208E-4848-ABAC-14E7EA2D0FFE

P698

Q37672615-84A6C6E4-54A7-4E7B-86C5-FCD3742004BC

P932

Q37672615-B55FAEF0-55FE-4972-8E04-C40F1C5D300B

P356

P1433

Canadian Respiratory Journal

P1476

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease.

@en

P2093

John Thenganatt

http://www.w3.org/2001/XMLSchema#string

Natalie K Kozij

http://www.w3.org/2001/XMLSchema#string

Philip E Silkoff

http://www.w3.org/2001/XMLSchema#string

Shobha Chakravorty

http://www.w3.org/2001/XMLSchema#string

P2860

Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Riociguat for the treatment of pulmonary arterial hypertension.

Nitric oxide in adult lung disease.

Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.

Modelling the production of nitric oxide within the human airways.

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival.

Exhaled markers of pulmonary disease.

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

P304

6736239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/6736239

http://www.w3.org/2001/XMLSchema#string

P407

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Sindhu R Johnson

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293128

http://www.w3.org/2001/XMLSchema#string

P932

5331166

http://www.w3.org/2001/XMLSchema#string